Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Gene Therapy|March 15, 2002
Bypassing tumor-specific and bispecific antibodies: triggering of antitumor immunity by expression of anti-FcgammaR scFv on cancer cell surfaceN Gruel, W H Fridman, J L TeillaudCancer Detection and Prevention|November 26, 1999
Ras and p53 intracellular targeting with recombinant single-chain Fv (scFv) fragments: a novel approach for cancer therapy?O Cochet, N Gruel, W H Fridman, et al.Preparative Biochemistry & Biotechnology|January 5, 2002
Purification of soluble recombinant human FcgammaRII (CD32)N Gruel, J Chapiro, W H Fridman, et al.Hybridoma|December 5, 1997
Production and characterization of mouse monoclonal antibodies to wild-type and oncogenic FLI-1 proteinsT Melot, N Gruel, A Doubeikovski, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 2, 1998
Structurally different anthracyclines provoke different effects on cell cycle and tumor B cell differentiationJ L Teillaud, N Gruel, J Moncuit, et al.Immunology Letters|March 5, 1999
Immunoglobulin variable regions usage by B-lymphocytes infiltrating a human breast medullary carcinomaB Kotlan, N Gruel, B Zafrani, et al.Oncogene|February 2, 1999
Restoration of transcriptional activity of p53 mutants in human tumour cells by intracellular expression of anti-p53 single chain Fv fragmentsC Caron de Fromentel, N Gruel, C Venot, et al.Hybridoma|February 10, 1998
A new set of monoclonal antibodies against human Fc gamma RII (CD32) and Fc gamma RIII (CD16): characterization and use in various assaysF Vely, N Gruel, J Moncuit, et al.Oncogene|February 2, 1999
A tumor specific single chain antibody dependent gene expression systemM N Mary, C Venot, C Caron de Fromentel, et al.Pageof 1